This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Gabriele Br Aunlich: Innovator in Pharmaceutical Chemistry
Introduction
Gabriele Br Aunlich is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address inflammatory diseases.
Latest Patents
One of his key patents is focused on amino-benzofuryl- and thienyl-derivatives. The patent describes a method for preparing 6-amino-benzofuryl- and thienyl-derivatives by reacting appropriate amino-substituted benzoyl phenols with substituted acetophenones. These compounds are particularly useful for treating both acute and chronic inflammatory diseases, especially those affecting the airways and the gastrointestinal tract. Gabriele holds 1 patent in this area.
Career Highlights
Gabriele Br Aunlich is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to focus on innovative solutions that enhance patient care and treatment options.
Collaborations
Throughout his career, Gabriele has collaborated with esteemed colleagues, including R Udiger Fischer and Mazen Es-Sayed. These partnerships have contributed to the advancement of research and development in his field.
Conclusion
Gabriele Br Aunlich's contributions to pharmaceutical chemistry and his innovative patent work demonstrate his commitment to improving healthcare solutions. His ongoing efforts continue to impact the treatment of inflammatory diseases positively.